Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glibenclamide (5mg) + Metformin (850mg) Tablet
Therapeutic Category
Antidiabetic, Cardiology, Diabetic
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Glibclay M 5-850 Tablet containing Glibenclamide and Metformin is used for the management of type 2 diabetes mellitus. It helps control blood sugar levels by improving insulin response and reducing glucose production.
Glibenclamide works by stimulating insulin secretion from the pancreas, while Metformin decreases hepatic glucose production and improves insulin sensitivity, providing dual-action blood sugar control.
The tablet is widely prescribed in diabetology and general medicine practice for effective long-term diabetes management, leading to consistent prescription demand.
With the rising prevalence of diabetes and increasing demand for effective combination therapies, this product offers strong business potential for retailers and distributors. Its dual mechanism of action, established clinical relevance, and steady market demand make it a reliable product for growth in the diabetology segment.
Some patients may experience hypoglycemia (low blood sugar), nausea, vomiting, abdominal discomfort, diarrhea, weight gain, or dizziness. Rarely, lactic acidosis (due to Metformin), liver dysfunction, or severe allergic reactions may occur and require immediate medical attention.
Glibclay M 5-850 Tablet is indicated for type 2 diabetes mellitus when diet, exercise, and single-drug therapy are not sufficient for glycemic control. It helps lower fasting and post-meal blood sugar levels and supports long-term diabetes management.
This medicine should be used strictly under medical supervision. Regular monitoring of blood glucose and kidney function is essential. Patients should avoid skipping meals to reduce the risk of hypoglycemia. Use cautiously in patients with kidney disease, liver impairment, or elderly individuals.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Gliclazide 80mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Glimepiride 1mg + Metformin 500mg + Pioglitazone 15mg Bi-Layered Tablets
Composition : Glimepiride (2mg) + Metformin (1000mg) SR Bilayered Smart Tablet
Composition : Glimepiride (1mg) + Metformin (500mg) SR Bilayered Smart Tablet
Composition : Glimepiride (2mg) Tablet
Composition : Glimepiride (1mg) Tablet
Composition : Glimepiride 2mg + Metformin Hydrochloride I.P. 500mg + Pioglitazone 15mg Bi-Layered Tablets
Composition : Glimepiride (2mg) + Metformin (500mg) SR + Voglibose (0.2mg) Bilayered Smart Tablet
Composition : Glimepiride (2mg) + Metformin (500mg) SR Bilayered Smart Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Glibenclamide 5mg + Metformin 850mg Tablet has strong demand in the diabetology, endocrinology, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on diabetes management portfolios.
Medical distributors and agencies can benefit from consistent demand for Type 2 diabetes management under medical supervision. Glibenclamide 5mg is a sulfonylurea antidiabetic agent that helps stimulate insulin release from the pancreas Metformin 850mg is a biguanide that helps improve insulin sensitivity and reduce glucose production by the liver Commonly prescribed for Type 2 Diabetes Mellitus when blood sugar control is not adequately achieved with lifestyle modifications or single-drug therapy The combination provides complementary mechanisms to support effective glycemic control Widely prescribed by diabetologists, endocrinologists, and general physicians This strengthens a comprehensive diabetes and chronic care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Glibenclamide 5mg + Metformin 850mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong prescription demand, long-term therapy usage, repeat monthly purchases, reliable supply chain support, and attractive margins in the antidiabetic segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.